Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches.

Journal of the International AIDS Society

Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, Markby J.
PMID: 26639120
J Int AIDS Soc. 2015 Dec 02;18:20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015.

INTRODUCTION: Despite significant gains in access to early infant diagnosis (EID) over the past decade, most HIV-exposed infants still do not get tested for HIV in the first two months of life. For those who are tested, the long...

Cite
Essajee S, Vojnov L, Penazzato M, et al. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc. 2015;18:20299doi: 10.7448/IAS.18.7.20299.
Essajee, S., Vojnov, L., Penazzato, M., Jani, I., Siberry, G. K., Fiscus, S. A., & Markby, J. (2015). Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. Journal of the International AIDS Society, 1820299. https://doi.org/10.7448/IAS.18.7.20299
Essajee, Shaffiq, et al. "Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches." Journal of the International AIDS Society vol. 18 (2015): 20299. doi: https://doi.org/10.7448/IAS.18.7.20299
Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, Markby J. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc. 2015 Dec 02;18:20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015. PMID: 26639120; PMCID: PMC4670838.
Copy Download .nbib Format: NLM
More people dying from TB are HIV-infected than previously recognized.

Central European journal of public health

[No authors listed]
PMID: 20020608
Cent Eur J Public Health. 2009 Sep;17(3):168.

No abstract available.

Cite
More people dying from TB are HIV-infected than previously recognized. Cent Eur J Public Health. 2009;17(3):168
(2009). More people dying from TB are HIV-infected than previously recognized. Central European journal of public health, 17(3), 168.
"More people dying from TB are HIV-infected than previously recognized." Central European journal of public health vol. 17,3 (2009): 168.
More people dying from TB are HIV-infected than previously recognized. Cent Eur J Public Health. 2009 Sep;17(3):168. PMID: 20020608.
Copy Download .nbib Format: NLM
Epidemiological metrics and benchmarks for a transition in the HIV epidemic.

PLoS medicine

Ghys PD, Williams BG, Over M, Hallett TB, Godfrey-Faussett P.
PMID: 30359372
PLoS Med. 2018 Oct 25;15(10):e1002678. doi: 10.1371/journal.pmed.1002678. eCollection 2018 Oct.

Peter Godfrey-Faussett and colleagues present six epidemiological metrics for tracking progress in reducing the public health threat of HIV.

Cite
Ghys PD, Williams BG, Over M, et al. Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Med. 2018;15(10):e1002678doi: 10.1371/journal.pmed.1002678.
Ghys, P. D., Williams, B. G., Over, M., Hallett, T. B., & Godfrey-Faussett, P. (2018). Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS medicine, 15(10), e1002678. https://doi.org/10.1371/journal.pmed.1002678
Ghys, Peter D, et al. "Epidemiological metrics and benchmarks for a transition in the HIV epidemic." PLoS medicine vol. 15,10 (2018): e1002678. doi: https://doi.org/10.1371/journal.pmed.1002678
Ghys PD, Williams BG, Over M, Hallett TB, Godfrey-Faussett P. Epidemiological metrics and benchmarks for a transition in the HIV epidemic. PLoS Med. 2018 Oct 25;15(10):e1002678. doi: 10.1371/journal.pmed.1002678. eCollection 2018 Oct. PMID: 30359372; PMCID: PMC6201869.
Copy Download .nbib Format: NLM
Infected women have faster risk of death, but reasons still unknown.

AIDS policy & law

[No authors listed]
PMID: 12164149
AIDS Policy Law. 1995 Jan 27;10(1):5, 9.

No abstract available.

Cite
Infected women have faster risk of death, but reasons still unknown. AIDS Policy Law. 1995;10(1):5, 9
(1995). Infected women have faster risk of death, but reasons still unknown. AIDS policy & law, 10(1), 5, 9.
"Infected women have faster risk of death, but reasons still unknown." AIDS policy & law vol. 10,1 (1995): 5, 9.
Infected women have faster risk of death, but reasons still unknown. AIDS Policy Law. 1995 Jan 27;10(1):5, 9. PMID: 12164149.
Copy Download .nbib Format: NLM
Getting to zero HIV deaths: progress, challenges and ways forward.

Journal of the International AIDS Society

Ford N, Vitoria M, Hirnschall G, Doherty M.
PMID: 24314398
J Int AIDS Soc. 2013 Dec 01;16:18927. doi: 10.7448/IAS.16.1.18927.

No abstract available.

Cite
Ford N, Vitoria M, Hirnschall G, et al. Getting to zero HIV deaths: progress, challenges and ways forward. J Int AIDS Soc. 2013;16:18927doi: 10.7448/IAS.16.1.18927.
Ford, N., Vitoria, M., Hirnschall, G., & Doherty, M. (2013). Getting to zero HIV deaths: progress, challenges and ways forward. Journal of the International AIDS Society, 1618927. https://doi.org/10.7448/IAS.16.1.18927
Ford, Nathan, et al. "Getting to zero HIV deaths: progress, challenges and ways forward." Journal of the International AIDS Society vol. 16 (2013): 18927. doi: https://doi.org/10.7448/IAS.16.1.18927
Ford N, Vitoria M, Hirnschall G, Doherty M. Getting to zero HIV deaths: progress, challenges and ways forward. J Int AIDS Soc. 2013 Dec 01;16:18927. doi: 10.7448/IAS.16.1.18927. PMID: 24314398; PMCID: PMC3854118.
Copy Download .nbib Format: NLM
All-Cause and Cancer-Specific Mortality Among Patients With Cancer Infected or Not Infected With HIV.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Dal Maso L, Serraino D.
PMID: 26598757
J Clin Oncol. 2016 Feb 01;34(4):388-90. doi: 10.1200/JCO.2015.64.4187. Epub 2015 Nov 23.

No abstract available.

Cite
Dal Maso L, Serraino D. All-Cause and Cancer-Specific Mortality Among Patients With Cancer Infected or Not Infected With HIV. J Clin Oncol. 2015;34(4):388-90doi: 10.1200/JCO.2015.64.4187.
Dal Maso, L., & Serraino, D. (2016). All-Cause and Cancer-Specific Mortality Among Patients With Cancer Infected or Not Infected With HIV. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(4), 388-90. https://doi.org/10.1200/JCO.2015.64.4187
Dal Maso, Luigino, and Serraino, Diego. "All-Cause and Cancer-Specific Mortality Among Patients With Cancer Infected or Not Infected With HIV." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34,4 (2016): 388-90. doi: https://doi.org/10.1200/JCO.2015.64.4187
Dal Maso L, Serraino D. All-Cause and Cancer-Specific Mortality Among Patients With Cancer Infected or Not Infected With HIV. J Clin Oncol. 2016 Feb 01;34(4):388-90. doi: 10.1200/JCO.2015.64.4187. Epub 2015 Nov 23. PMID: 26598757.
Copy Download .nbib Format: NLM
Maternal deaths and HIV treatment in sub-Saharan Africa.

Lancet (London, England)

Myer L.
PMID: 23683621
Lancet. 2013 May 18;381(9879):1699-700. doi: 10.1016/S0140-6736(13)61000-4.

No abstract available.

Cite
Myer L. Maternal deaths and HIV treatment in sub-Saharan Africa. Lancet. 2013;381(9879):1699-700doi: 10.1016/S0140-6736(13)61000-4.
Myer, L. (2013). Maternal deaths and HIV treatment in sub-Saharan Africa. Lancet (London, England), 381(9879), 1699-700. https://doi.org/10.1016/S0140-6736(13)61000-4
Myer, Landon. "Maternal deaths and HIV treatment in sub-Saharan Africa." Lancet (London, England) vol. 381,9879 (2013): 1699-700. doi: https://doi.org/10.1016/S0140-6736(13)61000-4
Myer L. Maternal deaths and HIV treatment in sub-Saharan Africa. Lancet. 2013 May 18;381(9879):1699-700. doi: 10.1016/S0140-6736(13)61000-4. PMID: 23683621.
Copy Download .nbib Format: NLM
When is the best time to initiate antiretroviral therapy?.

The lancet. HIV

Borges ÁH, Lundgren JD.
PMID: 26423369
Lancet HIV. 2015 Aug;2(8):e312-3. doi: 10.1016/S2352-3018(15)00122-8. Epub 2015 Jul 07.

No abstract available.

Cite
Borges ÁH, Lundgren JD. When is the best time to initiate antiretroviral therapy?. Lancet HIV. 2015;2(8):e312-3doi: 10.1016/S2352-3018(15)00122-8.
Borges, �. �. H., & Lundgren, J. D. (2015). When is the best time to initiate antiretroviral therapy?. The lancet. HIV, 2(8), e312-3. https://doi.org/10.1016/S2352-3018(15)00122-8
Borges, Álvaro H, and Lundgren, Jens D. "When is the best time to initiate antiretroviral therapy?." The lancet. HIV vol. 2,8 (2015): e312-3. doi: https://doi.org/10.1016/S2352-3018(15)00122-8
Borges ÁH, Lundgren JD. When is the best time to initiate antiretroviral therapy?. Lancet HIV. 2015 Aug;2(8):e312-3. doi: 10.1016/S2352-3018(15)00122-8. Epub 2015 Jul 07. PMID: 26423369.
Copy Download .nbib Format: NLM
[Lead time bias and its control in observational studies for clinical outcomes].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Zhang N, Liu HX, Kang DM, Wang N.
PMID: 29860822
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 May 10;39(5):700-703. doi: 10.3760/cma.j.issn.0254-6450.2018.05.032.

Lead time bias might exist in observational study for clinical outcomes. This paper summarizes the concept of lead time bias, causes and control of lead time bias by using the studies of influences of screening diagnostic test on cancer...

Cite
Zhang N, Liu HX, Kang DM, et al. [Lead time bias and its control in observational studies for clinical outcomes]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(5):700-703doi: 10.3760/cma.j.issn.0254-6450.2018.05.032.
Zhang, N., Liu, H. X., Kang, D. M., & Wang, N. (2018). [Lead time bias and its control in observational studies for clinical outcomes]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 39(5), 700-703. https://doi.org/10.3760/cma.j.issn.0254-6450.2018.05.032
Zhang, N, et al. "[Lead time bias and its control in observational studies for clinical outcomes]." Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 39,5 (2018): 700-703. doi: https://doi.org/10.3760/cma.j.issn.0254-6450.2018.05.032
Zhang N, Liu HX, Kang DM, Wang N. [Lead time bias and its control in observational studies for clinical outcomes]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018 May 10;39(5):700-703. doi: 10.3760/cma.j.issn.0254-6450.2018.05.032. Chinese. PMID: 29860822.
Copy Download .nbib Format: NLM
[Interrupted time series analysis for influence on HIV related fatality of implementation of 'Four Free Services One Care' policy in China].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Zhang HX, Han MJ, Zhou Y, Xiu XF, Xu F, Wang L.
PMID: 32294844
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Mar 10;41(3):406-411. doi: 10.3760/cma.j.issn.0254-6450.2020.03.024.

No abstract available.

Cite
Zhang HX, Han MJ, Zhou Y, et al. [Interrupted time series analysis for influence on HIV related fatality of implementation of 'Four Free Services One Care' policy in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(3):406-411doi: 10.3760/cma.j.issn.0254-6450.2020.03.024.
Zhang, H. X., Han, M. J., Zhou, Y., Xiu, X. F., Xu, F., & Wang, L. (2020). [Interrupted time series analysis for influence on HIV related fatality of implementation of 'Four Free Services One Care' policy in China]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 41(3), 406-411. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.03.024
Zhang, H X, et al. "[Interrupted time series analysis for influence on HIV related fatality of implementation of 'Four Free Services One Care' policy in China]." Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 41,3 (2020): 406-411. doi: https://doi.org/10.3760/cma.j.issn.0254-6450.2020.03.024
Zhang HX, Han MJ, Zhou Y, Xiu XF, Xu F, Wang L. [Interrupted time series analysis for influence on HIV related fatality of implementation of 'Four Free Services One Care' policy in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Mar 10;41(3):406-411. doi: 10.3760/cma.j.issn.0254-6450.2020.03.024. Chinese. PMID: 32294844.
Copy Download .nbib Format: NLM
Evolving chronic disease management in HIV care in an era of improved long-term survival.

Irish journal of medical science

Vijh R, O'Connell J, de Barra E, McConkey S.
PMID: 31338690
Ir J Med Sci. 2020 Feb;189(1):337-339. doi: 10.1007/s11845-019-02063-y. Epub 2019 Jul 23.

BACKGROUND: Adults ageing with HIV and on antiretroviral therapy have a greater burden of chronic diseases compared with adults without HIV as reported by Althoff et al. (Curr Opin HIV AIDS 11:527-36, 2016). Therefore, it is important in this...

Cite
Vijh R, O'Connell J, de Barra E, et al. Evolving chronic disease management in HIV care in an era of improved long-term survival. Ir J Med Sci. 2019;189(1):337-339doi: 10.1007/s11845-019-02063-y.
Vijh, R., O'Connell, J., de Barra, E., & McConkey, S. (2020). Evolving chronic disease management in HIV care in an era of improved long-term survival. Irish journal of medical science, 189(1), 337-339. https://doi.org/10.1007/s11845-019-02063-y
Vijh, Rohit, et al. "Evolving chronic disease management in HIV care in an era of improved long-term survival." Irish journal of medical science vol. 189,1 (2020): 337-339. doi: https://doi.org/10.1007/s11845-019-02063-y
Vijh R, O'Connell J, de Barra E, McConkey S. Evolving chronic disease management in HIV care in an era of improved long-term survival. Ir J Med Sci. 2020 Feb;189(1):337-339. doi: 10.1007/s11845-019-02063-y. Epub 2019 Jul 23. PMID: 31338690.
Copy Download .nbib Format: NLM
[Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies].

Medicina clinica

Pérez-Hoyos S.
PMID: 16834953
Med Clin (Barc). 2006 Jul 01;127(5):175-6. doi: 10.1157/13090711.

No abstract available.

Cite
Pérez-Hoyos S. Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos. [Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies]. Med Clin (Barc). 2006;127(5):175-6doi: 10.1157/13090711.
Pérez-Hoyos, S. (2006). Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos. [Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies]. Medicina clinica, 127(5), 175-6. https://doi.org/10.1157/13090711
Pérez-Hoyos, Santiago. "Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos." [Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies]. Medicina clinica vol. 127,5 (2006): 175-6. doi: https://doi.org/10.1157/13090711
Pérez-Hoyos S. Efecto del tratamiento antirretroviral de gran eficacia en la infección por el VIH: papel de los estudios epidemiológicos. [Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies]. Med Clin (Barc). 2006 Jul 01;127(5):175-6. doi: 10.1157/13090711. Spanish. PMID: 16834953.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries